BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li W, Wang X, Liu T, Zhang Q, Cao J, Jiang Y, Sun Q, Li C, Wang W, Wang Y. Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy. Front Cell Dev Biol 2022;10:813370. [DOI: 10.3389/fcell.2022.813370] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kawano I, Adamcova M. MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1055911] [Reference Citation Analysis]
2 Khairnar SI, Kulkarni YA, Singh K. Cardiotoxicity linked to anticancer agents and cardioprotective strategy. Arch Pharm Res 2022. [DOI: 10.1007/s12272-022-01411-4] [Reference Citation Analysis]
3 Ling G, Wang X, Tan N, Cao J, Li W, Zhang Y, Jiang J, Sun Q, Jiang Y, Wang W, Wang Y, Camara A. Mechanisms and Drug Intervention for Doxorubicin-Induced Cardiotoxicity Based on Mitochondrial Bioenergetics. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/7176282] [Reference Citation Analysis]
4 Ji Y, Jin D, Qi J, Wang X, Zhang C, An P, Luo Y, Luo J. Fucoidan Protects against Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Preventing Mitochondrial Function Injury. IJMS 2022;23:10685. [DOI: 10.3390/ijms231810685] [Reference Citation Analysis]
5 Li W, Zhang Y, Wang X, Cao J, Qian W, Ling G, Tan N, Jiang J, Sun Q, Li C, Wang W, Wang Y, Jakovljevic V. Qishen Granule Protects against Doxorubicin-Induced Cardiotoxicity by Coordinating MDM2-p53-Mediated Mitophagy and Mitochondrial Biogenesis. Oxidative Medicine and Cellular Longevity 2022;2022:1-17. [DOI: 10.1155/2022/4344677] [Reference Citation Analysis]